CINC424A2X01B Rollover Protocol

Clinical trial NCT02386800 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02386800
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Myelofibrosis Polycythemia Vera Graft Versus Host Disease Acute Myeloid Leukemia Thalassemia

Start date: 2015-03-05
Primary completion: 2027-09-16
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.